Addressing vaccine hesitancy and access barriers to achieve persistent progress in Israel’s COVID-19 vaccination programIntegrative Article Published on 2021-08-022022-10-30 Journal: Israel Journal of Health Policy Research [Category] COVID-19, MERS, [키워드] addressed administer Administered Adults affected age comparable Confusion contributed country Coverage COVID-19 vaccination distribution dose Effectiveness effort ENhance extension first dose General population group groups identify initial Initially Israelis Jew measure Measures moderate overcome rate of infection subgroup supplementary material the vaccine turn vaccination vaccination rates Vaccine vaccine for COVID-19 Vaccine hesitancy Vaccines [DOI] 10.1186/s13584-021-00481-x PMC 바로가기 [Article Type] Integrative Article
Vaccine allergy: evidence to consider for COVID-19 vaccines백신 알레르기: COVID-19 백신에 대해 고려해야 할 증거Review Published on 2021-08-012022-09-11 Journal: Current opinion in allergy and clinical immunology [Category] MERS, SARS, 치료제, [키워드] Allergic reactions allergy caused causes changed COVID-19 pandemic COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines derivative Diagnosis evaluate Evidence Frequency glycol identifying immunological mechanism medication Polyethylene glycol reaction Reactions recent required severe allergic reaction severe allergic reactions Side effect skin tests the disease the vaccine the vaccines vaccination Vaccine vaccine dose Vaccines [DOI] 10.1097/ACI.0000000000000762 PMC 바로가기 [Article Type] Review
Locally harvested Covid-19 convalescent plasma could probably help combat the geographically determined SARS-CoV-2 viral variants지역적으로 수확된 Covid-19 회복기 혈장은 아마도 지리적으로 결정된 SARS-CoV-2 바이러스 변이체를 퇴치하는 데 도움이 될 수 있습니다Article Published on 2021-08-012022-09-11 Journal: Transfusion clinique et biologique : journal de la [Category] MERS, SARS, 변종, 진단, [키워드] administer affected Antigen AstraZeneca Bharat Blood donors Blood safety CCP combating convalescent convalescent plasma COVID-19 COVID-19 convalescent plasma COVID-19 patients Donor registry drug effective Efficacy Epitopes help herd immunity Human plasma identify Immunity Inactivated vaccine India individual inherent live vaccine mind multiple epitope multiple epitopes Novel coronavirus Oxford pandemic pandemic status pathogen polyclonal researcher rising Russia SARS-CoV-2 variant SARS-CoV-2 variants SARS-CoV-2 viral SARS-CoV-2 virus the vaccine the vaccines United Kingdom Vaccine Vaccine impact variant variants Viral Viral variants [DOI] 10.1016/j.tracli.2021.05.003 PMC 바로가기 [Article Type] Article
Risk factors and predictors that influence SARS-Cov-2 IgG positivity: A cross-sectional study of blood donors in Riyadh, Saudi ArabiaSARS-Cov-2 IgG 양성에 영향을 미치는 위험 인자 및 예측 인자: 사우디 아라비아 리야드의 헌혈자를 대상으로 한 단면 연구Article Published on 2021-08-012022-09-12 Journal: Saudi medical journal [Category] MERS, SARS, 진단, [키워드] acute respiratory syndrome Anosmia asked Asymptomatic being Blood blood donor Blood donors city conducted coronavirus cough COVID-19 COVID-19 serological testing Critical cross-sectional demographic characteristics Developing Diagnosis Enrollment Factor IgG Immunity Immunoglobulin Infection King pandemic participant percentage predictor Prevalence question reported symptoms SARS-CoV-2 SARS-CoV-2 IgG SARS-COV-2 infection SARS-CoV-2 positivity Saudi Arabia Seroepidemiologic studies serological significantly higher Symptom symptomatic the vaccine university [DOI] 10.15537/smj.2021.42.8.20210238 PMC 바로가기 [Article Type] Article
Methods matter – Tailoring SARS-CoV-2 antibody targets to vaccination status방법이 중요 - 백신 접종 상태에 맞게 SARS-CoV-2 항체 표적 조정Article Published on 2021-08-012022-09-11 Journal: Clinica chimica acta; international journal of cli [Category] MERS, SARS, 진단, 치료법, [키워드] Anti-spike antibody assay Antibody test Antibody testing antibody tests Antigen approach Confusion COVID-19 COVID19 delineation develop IgG IgG antibody individual Infection Interpretation Laboratory mRNA vaccination nucleocapsid protein patient population SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 antibody testing serologic testing specific antigen spike Spike protein target the spike protein the vaccine vaccination Vaccine development [DOI] 10.1016/j.cca.2021.04.009 PMC 바로가기 [Article Type] Article
Reduction in COVID-19 prevalence in healthcare workers in a university hospital in southern Brazil after the start of vaccination예방 접종 시작 후 브라질 남부의 대학 병원에서 의료 종사자의 COVID-19 유병률 감소Article Published on 2021-08-012022-09-11 Journal: International Journal of Infectious Diseases [Category] SARS, 치료기술, [키워드] age Brazil ChAdOx1 ChAdOx1 nCoV-19 CoronaVac COVID-19 COVID-19 case COVID-19 diagnosis cross-sectional cross-sectional study detectable Diagnosis diagnosis of COVID-19 Effectiveness evaluated Fisher Fisher's exact test HCW HCWs healthcare healthcare worker Healthcare workers Hospitalization Infection institution level of significance Poisson regression Prevalence prevalence of COVID-19 previous diagnosis reduced reducing reduction RT-PCR SARS-CoV-2 severe COVID-19 Sex source of infection Spread SPSS software statistical analysis Symptom the vaccine university hospital vaccination Vaccine vaccine administration Vaccines variable [DOI] 10.1016/j.ijid.2021.07.025 PMC 바로가기 [Article Type] Article
SARS-CoV-2 vaccines – the biggest medical research project of the 21st centurySARS-CoV-2 백신 - 21세기 최대의 의학 연구 프로젝트Review Published on 2021-08-012022-09-11 Journal: Current opinion in virology [Category] SARS, 변종, 치료기술, [키워드] caused COVID-19 COVID-19 pandemic death disadvantage Disadvantages natural immunity pandemic platform reached reduce Research researcher SARS-CoV-2 SARS-CoV-2 vaccine the vaccine vaccine candidate Vaccine development Vaccines [DOI] 10.1016/j.coviro.2021.04.008 PMC 바로가기 [Article Type] Review
Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studiesBNT162b2 mRNA 백신의 실제 효과: 대규모 관찰 연구의 메타 분석Meta-Analysis Published on 2021-08-012022-09-11 Journal: Inflammopharmacology [Category] 임상, [키워드] 95% confidence interval adjusted approval BNT162b2 BNT162b2 mRNA BNT162b2 mRNA vaccine calculate Confidence intervals COVID-19 database Effectiveness eligible first dose hazard ratio identify Immunocompromised Immunocompromised patients incidence rate indicated meta-analyses Meta-analysis mRNA observational studies observational study of BNT162b2 patient population Prevent protective effect random-effects model rate ratio Real world reported RT-PCR SARS-CoV-2 second dose systematic literature search the vaccine Vaccine was performed were used [DOI] 10.1007/s10787-021-00839-2 PMC 바로가기 [Article Type] Meta-Analysis
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials성인에서 COVID-19에 대한 재조합 직렬 반복 이량체 RBD 기반 단백질 서브유닛 백신(ZF2001)의 안전성 및 면역원성: 2건의 무작위 배정, 이중 맹검, 위약 대조, 1상 및 2상 시험Clinical Trial Published on 2021-08-012022-09-12 Journal: The Lancet. Infectious Diseases [Category] MERS, SARS, 임상, 진단, [키워드] 95% CI Abstract Academy adverse event age allergy antibodies Antigen appear assigned Beijing biopharmaceutical center China Chinese Chongqing Contact Control COVID-19 COVID-19 cases COVID-19 vaccine determine development dimeric dose double-blind drug Efficacy eligible enrolled enrolment FIVE Follow-up geometric mean titre GMT group help immunogenic immunogenicity data intention-to-treat intramuscularly Laboratory magnitude Major material mechanism Mild moderate neutralising antibody Occurrence participant Participants per-protocol Phase 1 phase 1 trial phase 2 trial phase 3 trial Placebo placebo group placebo-controlled prevention Primary outcome priority Program protein subunit vaccine randomised Randomly RBD RBD-based protein subunit receive Registered reported Safety SARS-CoV SARS-CoV-2 SARS-COV-2 infection Science second dose Serious Adverse Event Serious Adverse Events seroconversion rate Seven Spike protein Spread Support technology the placebo group the receptor-binding domain the SARS-CoV-2 the vaccine translation Trial trials university hospital vaccination Vaccine vaccine group Vaccines was done ZF2001 [DOI] 10.1016/S1473-3099(21)00127-4 PMC 바로가기 [Article Type] Clinical Trial
A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated위약 그룹 백신 접종 후 COVID-19 백신 효과의 지속성을 평가하기 위한 지연 백신 접종 설계Article Published on 2021-08-012022-09-11 Journal: Annals of internal medicine [Category] SARS, 임상, [키워드] absence approach benefit blinded candidate vaccine clinical effectiveness COVID-19 demonstrated demonstration Effect Effects Efficacy Efficacy and safety estimate estimation Follow-up group less maintain Multiple occur offered Open-label Phase 3 Placebo placebo group placebo recipient placebo recipients placebo-controlled Prevent provide randomized clinical trials receive recipient the placebo group the vaccine Trial vaccination Vaccine vaccine efficacy vaccine group [DOI] 10.7326/M20-8149 PMC 바로가기 [Article Type] Article